Adrian Harel
12Patents
9h-index
5Co-inventors
65Inventor score
Filing activity: May 31, 1991 → Apr 14, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5605938A | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate | Emerging Cross-Sectional Technologies | 137 | Expired |
| US5994325A | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 92 | Expired |
| US6417173B1 | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 52 | Expired |
| US6083930A | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5705178A | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Human Necessities | 43 | Expired |
| US5705177A | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6020326A | Method for inhibition of bone growth by anionic polymers | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6756362B2 | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6127348A | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Emerging Cross-Sectional Technologies | 20 | Expired |
| US8247439B2 | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10739335B2 | Prognostic and diagnostic glycan-based biomarkers of brain damage | Physics | 1 | Active |
| US9975846B2 | Multivalent compounds for use in the treatment and prevention of brain damage | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.